The following is a searchable and filterable list of our news posts, press releases, white papers, articles, scientific posters, and much more.
If you can’t find something, please let us know and we’ll reach out to you as soon as we can.
Daten töten. Den Krebs.An article by Friedrich von Bohlen in FOCUS Die Welt in 2023 (in German)Download article
Molecular Health and collaborators prove new analytical approach that leverages real-world data to anticipate molecular causation of adverse drug reactionsPress release, 10 March 2022Read more
Application of a patient-centered reverse translational systems-based approach to understand mechanisms of an adverse drug reaction of immune checkpoint inhibitorsKim, S. et al. Clin Transl Sci. 2022 Jun;15(6):1430-1438. doi: 10.1111/cts.13254Open resource
Whole patient knowledge modeling of COVID-19 symptomatology reveals common molecular mechanismsBrock, S. et al. Front. Mol. Med. 2022, 2:1035290. https://doi.org/10.3389/fmmed.2022.1035290Open resource
The COVID-19 explorer – An integrated, whole patient knowledge model of COVID-19 diseaseBrock, S. et al. Front. Mol. Med. 2022, 2:1035215. https://doi.org/10.3389/fmmed.2022.1035215Open resource
Unlocking patient care and therapy breakthroughs from biomedical knowledgeCorporate Factsheet: We make precision medicine a reality for therapy developers, clinicians, and ultimately patientsRead more
Molecular Health and Essen University Hospital launch collaborative project to improve care for COVID-19 patientsPress release, 9 August 2021Read more
Wir bringen die biologische Grammatik in die MedizinPlattform Life Sciences “Smarte Medizin” – Interview with Friedrich von Bohlen (in German)Open resource
Target adverse event profiles for predictive safety in the postmarket settingPeter Schotland, Rebecca Racz, David B. Jackson, Theodoros G. Soldatos, Robert Levin, David G. Strauss and Keith Burkhart. Clinical Pharmacology & Therapeutics Volume 109, Issue 5, Pages: 1159-1362 (May 2021)Open resource
Molecular Health – intelligent solutions for smarter healthcareNATURE BiopharmaDealmakersOpen resource
Datenprojekt zu Covid-Langzeitfolgen startetHandelsblatt (in German)Open resource
Wie der MH Corona Explorer die Versorgung COVID-19-Kranker verbessern sollÄrzteZeitung (in German)Open resource
A case study of a patient-centered reverse translational systems-based approach to understand adverse event profiles in drug developmentKim, S. et al. Clin Transl Sci . 2022 Apr;15(4):1003-1013. doi: 10.1111/cts.13219Open resource
Advancing drug safety science by integrating molecular knowledge with post‐marketing adverse event reportsSoldatos, T. G. et al. CPT Pharmacometrics Syst Pharmacol. 2022 May;11(5):540-555. doi: 10.1002/psp4.12765Open resource